Morphine Extended-Release Capsules and Ustekinumab Subcutaneous
Determining the interaction of Morphine Extended-Release Capsules and Ustekinumab Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Morphine Extended-Release Capsules-Ustekinumab Subcutaneous Injection
- Morphine Extended-Release Capsules-Ustell
- Morphine Extended-Release Capsules-UTA
- Morphine Extended-Release Capsules-UTA Capsules
- Morphine Extended-Release Capsules-UTAC tablets
- Morphine Extended-Release Capsules-UTI Relief
- Ustekinumab Subcutaneous-Morphine Immediate-Release Tablets and Capsules
- Ustekinumab Subcutaneous-Morphine injection
- Ustekinumab Subcutaneous-Morphine Injection PF
- Ustekinumab Subcutaneous-Morphine Long-Acting Tablets
- Ustekinumab Subcutaneous-Morphine Oral Concentrate (20 mg/mL)
- Ustekinumab Subcutaneous-Morphine Oral Solution